Table I.

Cross-presentation by ISS-treated BMDCsa

ExperimentDividing OT-I CD8+ T Cells (%)
ABCDEFGHIJ
ISS/OVA25323742495057647272
OVA484812910141718
  • a The percentage of CFSE-labeled OT-I CD8+ T cells undergoing at least one division after incubation with DCs treated with ISS-ODN (1 μg/ml) plus OVA (0.1 μg/ml), or OVA (0.1 μg/ml) alone, as described in Fig. 2, are shown from 10 representative experiments.